Educational webinars dealing with the hottest topics in the clinical laboratory and pathology industry, presented by esteemed experts in the field.
Whether it’s the latest regarding compliance or regulatory issues, process improvement or quality management--just to name a few of the myriad topics we cover--DARK Daily webinars regularly bring you top subject matter from the most highly regarded faculty.Note: Registration for live webinar events closes 2 hours prior to event time. DVD of the recorded webinar is always available for purchase!
Speedy adoption of digital pathology systems and WSI can give your pathology group considerable competitive advantage. It can mean stronger relationships with referring physicians, more case referrals, expanded market share, increased revenue, and greater pathologist compensation for you and your colleagues. In these financially-stressful times, those are wonderful outcomes and they do help preserve and increase your annual income. That’s why it’s important for you to order this indispensable webinar today!
The Centers for Medicare & Medicaid Services are preparing to implement deep cuts to the Part B Clinical Laboratory Test Fee Schedule. Those cuts happen on January 1, 2018.
During this webinar, Lâle White of XIFIN will share the findings from her company’s analysis of the 300 million lab test claims that they process each year. This is the actual private payer price data XIFIN’s clients reported to CMS earlier this year. White will help you understand how CMS will use this data to cut the prices for specific tests, along with how your lab can model its test mix to predict how the lab fee cuts will lower your lab’s revenue next year.
Next, Julie Scott Allen, who represents NILA, will give you an up-to-the-minute report on how the clinical lab profession is negotiating with CMS to moderate the coming lab fee cuts. She will also provide you with an update on issues in Congress that affect clinical laboratories, including efforts by leading elected officials to change how CMS is preparing to use the PAMA rule to cut Part B lab test fees.